Clinical Trials Logo

Bronchiolitis Obliterans clinical trials

View clinical trials related to Bronchiolitis Obliterans.

Filter by:

NCT ID: NCT00177918 Recruiting - Clinical trials for Bronchiolitis Obliterans

Prospective Evaluations of Infectious Complication in Lung Transplant Recipients

Start date: August 2006
Phase:
Study type: Observational

The primary aim of this study is to determine prospectively the viral and C. pneumoniae infection prevalence and outcomes of infections in lung transplant recipients. The study will also determine the correlation of C. pneumoniae infection with the development of obliterans in lung transplant recipients.

NCT ID: NCT00163696 Recruiting - Asthma Clinical Trials

Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease

Start date: September 2004
Phase: N/A
Study type: Observational

The researchers are investigating a novel technique, the multi breath nitrogen washout technique, to measure airway changes in various respiratory diseases.

NCT ID: NCT00141726 Completed - Clinical trials for Respiratory Distress Syndrome, Adult

Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant

Start date: October 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effectiveness of etanercept in the treatment of patients with sub-acute lung injury following a bone marrow transplant. This study will also examine the toxicity of treatment with etanercept as well as whether there is an improved quality of life in these patients.

NCT ID: NCT00029328 Completed - Pneumonia Clinical Trials

Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation

Start date: September 2001
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the effects of etanercept, and define the toxicity, when administered to patients with acute non-infectious lung injury (idiopathic pneumonia syndrome, IPS) and with subacute pulmonary dysfunction after allogeneic stem cell transplantation.

NCT ID: NCT00027235 Completed - Clinical trials for Lung Diseases, Interstitial

Popcorn Lung: the Discovery of a New Disease

Start date: n/a
Phase: N/A
Study type: Observational

Recently, an epidemic of pulmonary disease has been recognized among workers in a popcorn factory in Jasper, Missouri. The exposure agent has not yet been identified, but suspects include butter flavoring and the powdered salt used in the mixing room. This disease resembles "Bronchiolitis Obliterans Syndrome", an illness that makes it difficult to breathe. Of the 117 workers studied, one year later, 25 subjects whom were working in the mixing room or in the microwave packaging area have had decreases in lung function seven times the norm for their age. Industrial hygiene experts revealed that dust concentrations of salt and other flavorings were much higher in the mixing room compared to the office and outdoor work areas. Recently, rats were exposed to vapors created by heating the butter flavor compound obtained from this plant. Six-hour exposure to vapors at very high concentration resulted in significant damage to the breathing apparatus. Thus, there is clinical, epidemiological, and animal toxicity data that appears to implicate some constituent present during the mixing of the butter flavoring, salt, and oil causing a form of obstructive airway disease that has been rapidly progressive in a number of workers. It is not clear what the pathophysiologic nature of this entity is, though it resembles Bronchiolitis Obliterans Syndrome. It is not known what the long term consequence of this will be on the active workers, nor is it clear whether preventive measures taken to reduce exposures in the mixing room and elsewhere in the plant are going to be effective.